Corrigendum: The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-02-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1163550/full |
| _version_ | 1828005639826178048 |
|---|---|
| author | Johannes B. Goll Steven E. Bosinger Steven E. Bosinger Steven E. Bosinger Steven E. Bosinger Travis L. Jensen Hasse Walum Tyler Grimes Gregory K. Tharp Muktha S. Natrajan Muktha S. Natrajan Azra Blazevic Richard D. Head Casey E. Gelber Kristen J. Steenbergen Nirav B. Patel Patrick Sanz Nadine G. Rouphael Nadine G. Rouphael Nadine G. Rouphael Evan J. Anderson Evan J. Anderson Mark J. Mulligan Mark J. Mulligan Mark J. Mulligan Mark J. Mulligan Daniel F. Hoft Daniel F. Hoft |
| author_facet | Johannes B. Goll Steven E. Bosinger Steven E. Bosinger Steven E. Bosinger Steven E. Bosinger Travis L. Jensen Hasse Walum Tyler Grimes Gregory K. Tharp Muktha S. Natrajan Muktha S. Natrajan Azra Blazevic Richard D. Head Casey E. Gelber Kristen J. Steenbergen Nirav B. Patel Patrick Sanz Nadine G. Rouphael Nadine G. Rouphael Nadine G. Rouphael Evan J. Anderson Evan J. Anderson Mark J. Mulligan Mark J. Mulligan Mark J. Mulligan Mark J. Mulligan Daniel F. Hoft Daniel F. Hoft |
| author_sort | Johannes B. Goll |
| collection | DOAJ |
| first_indexed | 2024-04-10T07:36:00Z |
| format | Article |
| id | doaj.art-cfd74444a3174492acd623dd7d76e410 |
| institution | Directory Open Access Journal |
| issn | 1664-3224 |
| language | English |
| last_indexed | 2024-04-10T07:36:00Z |
| publishDate | 2023-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj.art-cfd74444a3174492acd623dd7d76e4102023-02-23T12:50:29ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-02-011410.3389/fimmu.2023.11635501163550Corrigendum: The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studiesJohannes B. Goll0Steven E. Bosinger1Steven E. Bosinger2Steven E. Bosinger3Steven E. Bosinger4Travis L. Jensen5Hasse Walum6Tyler Grimes7Gregory K. Tharp8Muktha S. Natrajan9Muktha S. Natrajan10Azra Blazevic11Richard D. Head12Casey E. Gelber13Kristen J. Steenbergen14Nirav B. Patel15Patrick Sanz16Nadine G. Rouphael17Nadine G. Rouphael18Nadine G. Rouphael19Evan J. Anderson20Evan J. Anderson21Mark J. Mulligan22Mark J. Mulligan23Mark J. Mulligan24Mark J. Mulligan25Daniel F. Hoft26Daniel F. Hoft27Department of Biomedical Data Science and Bioinformatics, The Emmes Company, LLC, Rockville, MD, United StatesDivision of Microbiology & Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA, United StatesDepartment of Pathology & Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, United StatesEmory NPRC Genomics Core, Emory National Primate Research Center, Emory University, Atlanta, GA, United StatesEmory Vaccine Center, Emory University School of Medicine, Atlanta, GA, United StatesDepartment of Biomedical Data Science and Bioinformatics, The Emmes Company, LLC, Rockville, MD, United StatesDivision of Microbiology & Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA, United StatesDepartment of Biomedical Data Science and Bioinformatics, The Emmes Company, LLC, Rockville, MD, United StatesEmory NPRC Genomics Core, Emory National Primate Research Center, Emory University, Atlanta, GA, United StatesEmory Vaccine Center, Emory University School of Medicine, Atlanta, GA, United StatesHope Clinic of the Emory Vaccine Center, Emory University, Atlanta, GA, United StatesDivision of Infectious Diseases, Allergy, and Immunology, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO, United StatesMcDonnell Genome Institute, Washington University, St. Louis, MO, United StatesDepartment of Biomedical Data Science and Bioinformatics, The Emmes Company, LLC, Rockville, MD, United StatesDepartment of Biomedical Data Science and Bioinformatics, The Emmes Company, LLC, Rockville, MD, United StatesEmory NPRC Genomics Core, Emory National Primate Research Center, Emory University, Atlanta, GA, United StatesOffice of Biodefense, Research Resources and Translational Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United StatesEmory Vaccine Center, Emory University School of Medicine, Atlanta, GA, United StatesHope Clinic of the Emory Vaccine Center, Emory University, Atlanta, GA, United States0Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Emory University, Atlanta, GA, United States0Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Emory University, Atlanta, GA, United States1Center for Childhood Infections and Vaccines (CCIV) of Children’s Healthcare of Atlanta and Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United StatesEmory Vaccine Center, Emory University School of Medicine, Atlanta, GA, United StatesHope Clinic of the Emory Vaccine Center, Emory University, Atlanta, GA, United States0Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Emory University, Atlanta, GA, United States2New York University Vaccine Center, New York, NY, United StatesDivision of Infectious Diseases, Allergy, and Immunology, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO, United States3Department of Molecular Microbiology & Immunology, Saint Louis University, St. Louis, MO, United Stateshttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1163550/fullRNA-Seqstatistical powerERCCtularemia vaccine (DVC-LVS)gene filteringsequencing depth |
| spellingShingle | Johannes B. Goll Steven E. Bosinger Steven E. Bosinger Steven E. Bosinger Steven E. Bosinger Travis L. Jensen Hasse Walum Tyler Grimes Gregory K. Tharp Muktha S. Natrajan Muktha S. Natrajan Azra Blazevic Richard D. Head Casey E. Gelber Kristen J. Steenbergen Nirav B. Patel Patrick Sanz Nadine G. Rouphael Nadine G. Rouphael Nadine G. Rouphael Evan J. Anderson Evan J. Anderson Mark J. Mulligan Mark J. Mulligan Mark J. Mulligan Mark J. Mulligan Daniel F. Hoft Daniel F. Hoft Corrigendum: The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies Frontiers in Immunology RNA-Seq statistical power ERCC tularemia vaccine (DVC-LVS) gene filtering sequencing depth |
| title | Corrigendum: The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies |
| title_full | Corrigendum: The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies |
| title_fullStr | Corrigendum: The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies |
| title_full_unstemmed | Corrigendum: The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies |
| title_short | Corrigendum: The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies |
| title_sort | corrigendum the vacc seqqc project benchmarking rna seq for clinical vaccine studies |
| topic | RNA-Seq statistical power ERCC tularemia vaccine (DVC-LVS) gene filtering sequencing depth |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1163550/full |
| work_keys_str_mv | AT johannesbgoll corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT stevenebosinger corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT stevenebosinger corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT stevenebosinger corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT stevenebosinger corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT travisljensen corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT hassewalum corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT tylergrimes corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT gregoryktharp corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT mukthasnatrajan corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT mukthasnatrajan corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT azrablazevic corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT richarddhead corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT caseyegelber corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT kristenjsteenbergen corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT niravbpatel corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT patricksanz corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT nadinegrouphael corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT nadinegrouphael corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT nadinegrouphael corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT evanjanderson corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT evanjanderson corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT markjmulligan corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT markjmulligan corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT markjmulligan corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT markjmulligan corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT danielfhoft corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies AT danielfhoft corrigendumthevaccseqqcprojectbenchmarkingrnaseqforclinicalvaccinestudies |